These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8765218)

  • 21. The use and limitations of the INR system.
    Ts'ao C; Neofotistos D
    Am J Hematol; 1994 Sep; 47(1):21-6. PubMed ID: 8042611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins.
    Kitchen S; Preston FE
    J Clin Pathol; 1997 Nov; 50(11):951-6. PubMed ID: 9462248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.
    Oskarsdóttir AR; Gudmundsdottir BR; Indridason OS; Lund SH; Arnar DO; Bjornsson ES; Magnusson MK; Jensdottir HM; Vidarsson B; Francis CW; Onundarson PT
    J Thromb Thrombolysis; 2017 May; 43(4):550-561. PubMed ID: 28214948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
    Robert A; Chazouillères O
    Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASHP therapeutic position statement on the use of the International Normalized Ratio system to monitor oral anticoagulant therapy.
    Am J Health Syst Pharm; 1995 Mar; 52(5):529-31. PubMed ID: 7606561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring warfarin therapy with the international normalized ratio.
    Howard PA
    Ann Pharmacother; 1994 Feb; 28(2):242-4. PubMed ID: 8173144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring warfarin therapy in patients with lupus anticoagulants.
    Moll S; Ortel TL
    Ann Intern Med; 1997 Aug; 127(3):177-85. PubMed ID: 9245222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harmonizing the International Normalized Ratio (INR) : Standardization of Methods and Use of Novel Strategies to Reduce Interlaboratory Variation and Bias.
    Favaloro EJ; McVicker W; Lay M; Ahuja M; Zhang Y; Hamdam S; Hocker N
    Am J Clin Pathol; 2016 Feb; 145(2):191-202. PubMed ID: 26800763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Warfarin monitoring independent of the international normalized ratio (INR): a pilot study.
    Carroll WE; Jackson RD
    Res Commun Mol Pathol Pharmacol; 1997 Feb; 95(2):169-78. PubMed ID: 9090753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The need for an adapted initiation nomogram during Fiix prothrombin time monitoring of warfarin.
    Onundarson PT; Gudmundsdottir BR
    J Thromb Thrombolysis; 2019 Nov; 48(4):685-689. PubMed ID: 31401717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of the International Normalized Ratio to generate consistent results within a local medical community.
    Ng VL; Levin J; Corash L; Gottfried EL
    Am J Clin Pathol; 1993 Jun; 99(6):689-94. PubMed ID: 8322703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
    Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
    Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of an Increase in Prothrombin Time-International Normalized Ratio by Interaction Between Warfarin and Baloxavir Marboxil in a Patient on Implantable Ventricular Assist Device.
    Kurosawa K; Takasaki S; Suzuki H; Sato Y; Akiyama M; Akiba M; Saiki Y; Mano N
    J Pharm Pharm Sci; 2021; 24():37-40. PubMed ID: 33460556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The agreement between capillary and venous sampling for plasma PT/INR results.
    Lindström J; Henriksson AE
    Scand J Clin Lab Invest; 2018 Oct; 78(6):524-526. PubMed ID: 30261743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reliability of international normalized ratios during short-term oral anticoagulant treatment.
    McKernan A; Thomson JM; Poller L
    Clin Lab Haematol; 1988; 10(1):63-71. PubMed ID: 3365933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin monitoring by an anticoagulant therapy factor (ATF).
    Carroll WE; Jackson RD; Carroll TA
    Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):159-70. PubMed ID: 9821212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.